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Abstract
Background: Telomere length and DNA methylation have been proposed as biological
clock measures that track chronological age. Whether they change in tandem, or contrib-
ute independently to the prediction of chronological age, is not known.
Methods: We address these points using data from two Scottish cohorts: the Lothian
Birth Cohorts of 1921 (LBC1921) and 1936 (LBC1936). Telomere length and epigenetic
clock estimates from DNA methylation were measured in 920 LBC1936 participants (ages
70, 73 and 76 years) and in 414 LBC1921 participants (ages 79, 87 and 90 years).
Results: The epigenetic clock changed over time at roughly the same rate as chronolo-
gical age in both cohorts. Telomere length decreased at 48–67 base pairs per year on
average. Weak, non-significant correlations were found between epigenetic clock esti-
mates and telomere length. Telomere length explained 6.6% of the variance in age in
LBC1921, the epigenetic clock explained 10.0%, and combined they explained 17.3% (all
P < 1  107). Corresponding figures for the LBC1936 cohort were 14.3%, 11.7% and
19.5% (all P < 1  1012). In a combined cohorts analysis, the respective estimates were
2.8%, 28.5% and 29.5%. Also in a combined cohorts analysis, a one standard deviation in-
crease in baseline epigenetic age was linked to a 22% increased mortality risk (P ¼ 2.6 
104) whereas, in the same model, a one standard deviation increase in baseline telo-
mere length was independently linked to an 11% decreased mortality risk (P ¼ 0.06).
VC The Author 2016. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
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Conclusions: These results suggest that telomere length and epigenetic clock estimates
are independent predictors of chronological age and mortality risk.
Key words: Epigenetic clock, telomeres, ageing, longitudinal, mortality
Introduction
Biological clocks present an exciting opportunity to track
and help understand ageing. For example, we can investi-
gate differences in biological age for individuals of the
same chronological age to see how environmental factors
influence biological ageing rates. Numerous clocks have
been proposed, with varying accuracy in predicting
chronological age. Two of the most promising clocks have
been based on telomere length1 and DNA methylation2–4
Telomeres are short sections of DNA and protein that cap
the ends of chromosomes, protecting them from damage.
They typically shorten over the life course, such that they
have been used as biomarkers of ageing and age-related
disease.5–7 In the most recent systematic review, the correl-
ation between telomere length and chronological age was
reported to be around 0.3.1 Studies have described links
between shorter telomere length and obesity,8 cancer,9,10
diabetes11 and cardiovascular disease.12 There is also
growing evidence to indicate that women have longer telo-
meres than men, although there remains some variability,
particularly with regard to differing technologies and
measurement issues.13 To date, there have been few studies
examining longitudinal telomere change. Typically these
have been carried out in small samples and at only two
time points.1,14
Biological markers of ageing have been derived from
DNA methylation data. DNA methylation represents
chemical modifications to the genome and is involved in
the regulation of genes. In 2013, Hannum et al. used infor-
mation from 71 CpG sites (measured in whole blood) to
predict chronological age in 656 individuals.2 They found
a correlation of 0.96 between their measure and actual
age. Other DNA methylation-based biological markers of
ageing, also known as epigenetic clocks, have been derived
using methylation data from multiple tissue sources.3
Studies have linked faster-running epigenetic clocks to
higher mortality risk,15 and cross-sectionally to cognitive
and physical health,16 but not to other health outcomes
such as smoking, diabetes, and heart disease or to genetic
factors such as APOE.15
In the present study we use longitudinal data on both
telomere length and DNA methylation to determine if:
(i) the epigenetic clock correlates with telomere length;
(ii) baseline epigenetic clock estimates associate with
changes in telomere length; (iii) the epigenetic clock and
telomere length correlate with age independently; (iv) the
epigenetic clock and telomere length associate with mortal-
ity risk independently; and (v) there are any epigenome-
wide associations between telomere length and individual
CpGs.
Methods
Lothian Birth Cohorts
Data came from the Lothian Birth Cohorts of 1921 and
1936 (LBC1921 and LBC1936), which are longitudinal
studies of ageing.17–19 The cohorts contain individuals
born in either 1921 or 1936, who participated in the
Scottish Mental Surveys of 1932 or 1947 when nearly all
11-year-old children sat a cognitive test. Most of the par-
ticipants were living in the City of Edinburgh or its sur-
rounding (Lothians) area of Scotland in later life when the
studies commenced. In LBC1921, 550 participants were
recruited at mean age 79 and have completed up to five
clinical examinations at mean ages 79, 83, 87, 90 and 92.
In LBC1936, 1091 participants were recruited at age 70
and have completed up to three clinical examinations at
Key Messages
• Telomere length and DNA methylation are potential biological markers of ageing.
• They do not correlate in later life between ages 70 and 90.
• They associate independently with chronological age.
• Both are predictors of mortality in an older population.
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mean ages 70, 73 and 76. In both cohorts, detailed infor-
mation has been obtained on lifestyle and health outcomes,
genetics and epigenetics.
LBC consent
Following written informed consent, venesected whole blood
was collected for DNA extraction in both LBC1921 and
LBC1936. Ethics permission for the LBC1921 was obtained
from the Lothian Research Ethics Committee (wave 1:
LREC/1998/4/183; wave 3:1702/98/4/183) and the Scotland
A Research Ethics Committee (wave 4:10/S1103/6). Ethics
permission for the LBC1936 was obtained from the Multi-
Centre Research Ethics Committee for Scotland (wave 1:
MREC/01/0/56), the Lothian Research Ethics Committee
(wave 1: LREC/2003/2/29) and the Scotland A Research
Ethics Committee (waves 2 and 3: 07/MRE00/58).
DNA methylation
A detailed protocol describing DNA measurement in the
Lothian Birth Cohorts has been presented previously.20
Briefly, methylation measurements from whole blood were
taken from LBC1936 participants at waves 1 (age 70, n ¼
1004), 2 (age 73, sub-group n ¼ 336) and 3 (age 76, sub-
group n ¼ 332) and from LBC1921 participants at waves 1
(age 79, n ¼ 517), 3 (age 87, n ¼ 181) and 4 (age 90, n ¼
87). The Illumina HumanMethylation450 BeadChips array
was used to measure DNA methylation at 485-512 sites.
Quality control (QC) was carried out on these data to re-
move: (i) probes with a low detection rate; (ii) low-quality
samples; (iii) samples with a low call rate; and (iv) samples
where there was a sex mismatch. Post-QC there were
450 726 autosomal probes available for analysis in 920,
299 and 273 participants at the three LBC1936 waves, re-
spectively, and in 446, 175 and 82 participants at the three
LBC1921 waves, respectively (Table 1). Of these probes, 71
were used to calculate DNA methylation age using the re-
gression weights supplied by Hannum et al.2 Hereafter, we
refer to this quantity as Hannum age or Hannum epigenetic
clock estimates. For the epigenome-wide association studies,
beta values were corrected for effects of sample plate,
BeadChip, position on BeadChip and hybridization date,
using a generalized linear model with a logistic link func-
tion. Residuals from this model were used in further
analyses.
Telomere measurement
Telomere length was measured at the same waves as methy-
lation in both LBC cohorts (LBC1921 at waves 1, 3 and 4,
and in LBC1936 at waves 1, 2 and 3; Table 1) using a quan-
titative real-time polymerase chain reaction (PCR) assay.21
Four internal control DNA samples were run within each
plate to correct for plate-to-plate variation. PCRs were per-
formed on an Applied Biosystems (Pleasonton, CA, USA)
7900HT Fast Real Time PCR machine.
Mortality ascertainment
For both LBC1921 and LBC1936, mortality status was ob-
tained via data linkage from the National Health Service
Central Register, provided by the General Register Office
for Scotland (now National Records of Scotland).
Participant deaths and cause of death are routinely flagged
to the research team on an approximately a 12-weekly
basis.
Statistical analyses
Pearson correlations were calculated between the Hannum
epigenetic clock estimates (Hannum age) and telomere
Table 1. Summary descriptive data for the Lothian Birth Cohorts of 1921 and 1936; mean (SD) or n (%)
Wave n Age (yrs) Sex (F) Telomere length (bp) Nmethylation Hannum methylation
age (yrs)
LBC1936
1 1070 69.5 (0.8) 530 (50) 4201 (560) 920 65.9 (6.5)
2 853 72.5 (0.7) 409 (48) 3966 (738)a 299 67.2 (6.7)
3 691 76.2 (0.7) 331 (48) 3739 (686) 273 71.5 (6.1)
LBC1921
1 529 79.1 (0.6) 308 (58) 4089 (413)b 446 73.7 (7.0)
3 189 86.6 (0.4) 101 (53) 4209 (564)c 174 77.7 (5.9)
4 92 90.1 (0.1) 48 (52) 3179 (722) 82 79.3 (6.1)
F, female; yrs, years.
a9 samples missing.
b32 samples missing.
c43 samples missing.
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length at each wave in both LBC1921 and LBC1936.
Linear mixed models were used to examine independently
the longitudinal changes in telomere length and Hannum
age.22 Sex was included as a covariate, age as the timescale
and participant as a random effect on the intercept. Across
all of our mixed effects models, there was no statistical evi-
dence for the inclusion of a person-specific random slope
parameter. Interaction terms were included to test whether
men and women changed at different rates. A mixed model
(with age and sex as fixed effects, and a participant ran-
dom effect on the intercept) was used to examine the
change in telomere length that was predicted by baseline
epigenetic age acceleration (residuals from a linear regres-
sion of Hannum age on chronological age); the coefficient
of interest in this model was the interaction term between
baseline age acceleration and chronological age.
Interactions between sex and chronological age were also
investigated. With age as the dependent variable, linear
mixed effects models were used to model the longitudinal
change in chronological age as a function of telomere
length and Hannum age. We first examined the variables
independently, and then together in the same model. To
obtain approximate R2 estimates for the respective models,
we re-ran the analysis using linear regression on a ran-
domly sampled subset of the data whereby each individual
was allowed to provide information to only a single wave.
Finally, we combined the two cohorts into a single sample
and re-ran the age prediction analyses described above. For
the survival (time-to-death) analyses, Cox proportional
hazards models were built using baseline data on age, telo-
mere length and Hannum age as predictors along with sex.
An epigenome-wide association study (EWAS) was per-
formed in both LBC1921 and LBC1936, using telomere
data from all waves. Linear mixed models were run with
the CpG probes as the dependent variable and telomere
length as the independent variable of interest; covariates
included age, sex, estimated white blood cell counts23 as
fixed effects and individual participant ID as a random ef-
fect. A standard error-based meta-analysis of the EWAS re-
sults was performed in METAL.24 All other analyses were
conducted in R, using the ‘lme4’, ‘lmerTest’ and ‘survival’
libraries.25–28
Results
A summary of the Lothian Birth Cohort data is presented
in Table 1, with a breakdown of the sample by number of
waves completed presented in Supplementary Tables 1
and 2 (available as Supplementary data at IJE online).
The small standard deviations for age emphasise that all
participants (in the respective cohorts) were born in the
same year. There is modest attrition (27% of the sample)
over time in the younger 1936 cohort, with a much
greater loss of individuals over the longer period in the
older cohort (77% of the sample); most of the dropout is
due to mortality, as shown in the Cox models in
Supplementary Table 3 (available as Supplementary data
at IJE online). Individuals with shorter telomeres at base-
line were more likely to drop out of LBC1921, although
there was little difference in baseline telomere length and
dropout in LBC1936 (Supplementary Tables 1 and 2).
The gender balance remains consistent in both cohorts
over time. Hannum age point estimates are, on average,
slightly lower than chronological age but show a mean in-
crease over time; average telomere length shortens over
time.
Correlations between telomere length and the
epigenetic clock
The correlations between telomere length and Hannum
age are reported in Table 2. There were no significant asso-
ciations or consistent direction of association between the
measures at any of the waves in either of the cohorts. The
correlation coefficients were small, not exceeding 0.047
(SE¼ 0.06) in LBC1936. In the smaller LBC1921, the
largest correlation was 0.12, which carried a standard
error of 0.09.
Change in telomere length and the epigenetic
clock over time
Both telomere length and Hannum age changed over time
in the two cohorts (Figure 1). In LBC1936, telomere length
decreased over the 6-year follow-up by an average of
0.098 (SE 0.005, P < 21016) standard deviations (the
standard deviation was derived using telomere data from
across all waves; the decline is equivalent to a drop of 67
Table 2. Pearson correlations between Hannum methylation
age and telomere length
Cohort n r (SEa) P-value
LBC1936
Wave 1 (age 70 yrs) 920 0.019 (0.033) 0.56
Wave 2 (age 73 yrs) 290 0.011 (0.059) 0.85
Wave 3 (age 76 yrs) 273 0.047 (0.061) 0.44
LBC1921
Wave 1 (age 79 yrs) 414 0.020 (0.049) 0.68
Wave 3 (age 87 yrs) 131 0.117 (0.087) 0.18
Wave 4 (age 90 yrs) 82 0.062 (0.111) 0.58
yrs, years.
aApproximate standard errors were calculated using the formula ((1-r2)/
(n-2).
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base pairs) per year. Hannum age increased by an average
of 0.14 (SE 0.007, P < 2  1016) standard deviations per
year, which is equivalent to 0.96 epigenetic clock-years per
calendar year. Similar associations were seen in LBC1921,
where telomere length decreased by 0.083 (SE 0.008, P <
2  1016) standard deviations (equivalent to 48 base
pairs) per year on average, and Hannum age increased by
0.085 (SE 0.006, P < 2  1016) standard deviations per
year (0.60 years per calendar year) on average. In
LBC1936 but not LBC1921, there was evidence for an
interaction between rate of decline in telomere length and
sex. Men declined faster by an average of 0.04 SDs ( 29
base pairs, P ¼ 5.9  106) per year. In a pooled analysis
of both cohorts, telomere length declined at an average of
37 (SE 2, P < 2  1016) base pairs per year, whereas
Hannum age increased by 0.76 years per calendar year (SE
0.02, P < 2  1016). There was an interaction between
gender and rate of telomere change—men declined faster
by an average of 10 (SE 4, P ¼ 0.017) base pairs per year.
Baseline methylation age acceleration (defined as the re-
siduals from the regression of Hannum age on chronolo-
gical age) did not predict longitudinal decline in telomere
length in LBC1921 (beta ¼ 4.8 103, SE¼8.9  103,
P ¼ 0.59), LBC1936 (beta¼3.5  103, SE¼4.9 
103, P ¼ 0.48), or in a pooled analysis (beta¼5.7 
104, SE¼ 3.6  103, P ¼ 0.88).
Telomere length and the epigenetic clock as
predictors of age
The LBC1936 linear regression models with age as the de-
pendent variable yielded R2 coefficients of 6.6% for telo-
mere length, 10.0% for Hannum age and 17.3% for the
model with both (all P < 1  1012). The corresponding
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Figure 1. Spaghetti plots for change in Hannum age and telomere length over time in LBC1936 and LBC1921.
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estimates in LBC1921 were 14.3% for telomere length and
11.7% for Hannum age. In the model with both predictors,
the R2 estimate increased to 19.5% (all P < 1  107). The
results for both LBC cohorts are presented in Figure 2. In
the combined cohorts analysis, the R2 coefficients for telo-
mere length and Hannum age were 2.8% and 28.5%, re-
spectively, with 29.5% of the variance explained in the
model with both predictors. Supplementary Table 4 (avail-
able as Supplementary data at IJE online) shows the regres-
sion coefficients for the linear model where each participant
contributed to no more than one time point, and the linear
mixed model that included ID as a random effect.
Telomere length and the epigenetic clock as
predictors of mortality
The results from the survival analyses for all-cause mortal-
ity are reported in Table 3. In a baseline-age, and sex ad-
justed model in LBC1921, longer baseline telomere length
was associated with a decreased mortality risk—hazard
ratio ¼ 0.86 (per standard deviation change; and 95% con-
fidence interval ¼ 0.75, 0.97, P ¼ 0.015)—whereas a
higher Hannum age was associated with an increased mor-
tality risk of 1.22 (1.08, 1.39), P ¼ 0.001 (also per standard
deviation change). In LBC1936, the corresponding esti-
mates were 0.96 (0.80, 1.14), P ¼ 0.63 for telomere length
and 1.18 (1.01, 1.38), P ¼ 0.040 for Hannum age. For
both cohorts, the Hannum age associations with mortality
have been reported previously.16 However, these associ-
ations were independent of telomere length. In a pooled co-
horts analysis, an older Hannum age was associated with
an increased mortality risk [HR 1.22 (1.10, 1.37), P ¼ 2.6
 104]; there was a borderline-significant protective effect
of increased telomere length [HR 0.89 (0.80, 1.01), P ¼
0.06]. The all-cause mortality associations for telomere
length and Hannum age without mutual adjustment are re-
ported in Supplementary Table 3.
Replication with the Horvath methylation age
predictor
Re-running the above analyses with the Horvath predictor3
in place of the Hannum measure yielded near identical find-
ings. The Horvath measure correlated between 0.08 and
0.19 with telomere length. The latter correlation was statistic-
ally significant (P ¼ 0.031) although this was at wave 3 of
LBC1921 where the sample size is small (n ¼ 131). Baseline
Horvath age acceleration did not predict longitudinal change
in telomere length (standardized beta 1.5  103, SE 3.8 
103, P ¼ 0.70). In the age prediction models, both Horvath
age and telomere length were independently associated with
age—the effect sizes for telomere length are very similar to
those from the Hannum models (results not shown). Similar
independent findings are observed in the mortality survival
models and the estimates map neatly to those from the
Hannum models (results not shown).
Epigenome-wide association study of telomere
length
The epigenome-wide association study analysis revealed a
single hit in both cohorts after a Bonferroni correction for
Figure 2. Proportion of variance in age explained by Hannum age and telomere length. For each panel, the bars represent the findings for telomere
length, Hannum age, and their additive effect, respectively.
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multiple testing (Supplementary Figure 1, available as
Supplementary data at IJE online). Telomere length was
associated with cg20489909 (P ¼ 7.6  108) on chromo-
some 2 in LBC1921 and cg11606261 (P ¼ 2.5  108) on
chromosome 12 in LBC1936. The genomic inflation statis-
tics for the two models were 0.93 and 1.02, respectively.
The LBC1921 hit was not significant in LBC1936 (P ¼
0.27), whereas the LBC1936 hit was nominally (P < 0.05)
significant in LBC1921 (P ¼ 0.005) but with an effect size
in the opposite direction. In a meta-analysis of the results
there were no epigenome-wide significant hits
(Supplementary Figure 1).
Discussion
These analyses find that telomere length and epigenetic
clock estimates are uncorrelated in later life and that they
are independent predictors of chronological age, in similar
magnitude. The epigenetic clock estimates and telomere
length are both associated independently with mortality
risk in LBC1921; only the epigenetic clock estimates are
associated with mortality in LBC1936. Where significant,
the effect sizes are in the expected directions—shorter telo-
meres and a faster running epigenetic clock (older epigen-
etic age relative to those of a similar chronological age) are
associated with an increased mortality risk. There were no
individual CpG associations with telomere length in the
EWAS meta-analysis.
These findings are important for ageing research as they
point towards different pathways/mechanisms that are
being tagged by telomeres and the epigenetic clock. What
these might be is beyond the scope of the current study.
In terms of the disease-related and health outcome-related
pathways, larger studies and collaborative efforts will be
required to link both telomere length and the epigenetic
clock to such outcomes. For example, in a study of the epi-
genetic clock and mortality using data from four cohorts,
no consistent associations were found between it and
measures such as education, type 2 diabetes, hypertension,
apolipoprotein E (APOE) status, smoking or cardiovascu-
lar disease.15 There were consistent sex differences, with
men having a faster running clock.3,15 Previous research
using LBC1936 data has also shown cross-sectional associ-
ations between epigenetic clock estimates and cognitive
ability and physical fitness (grip strength and lung func-
tion, but not walking speed).16 There is also evidence to
link accelerated epigenetic ageing in those with Down
Syndrome,29 in addition to a faster running epigenetic
clock in the livers of obese individuals.30 Previous studies
of telomeres have linked shorter length to obesity, cardio-
vascular disease and diabetes, but not to physical or cogni-
tive decline.8–12,31
In the present study, we focused on the Hannum epigen-
etic clock2 in favour of the multi-tissue derived clock built
by Horvath,3 due to the same tissue (with the same white
blood cell confounders) being relevant to both the
Hannum clock and the telomere lengths. However, re-
running the models with the Horvath predictor yielded
near identical findings. One peculiarity of our data is the
‘increase’ in telomere length between ages 79 and 87 in
LBC1921 (Supplementary Table 2). However, upon the
exclusion of individuals not present at both waves, where
dropout was primarily due to death, the mean telomere
lengths appears to be stable rather than increasing
(Supplementary Table 2). Similarly, we also observe longer
telomeres in the LBC1921 participants at age 79 compared
with the LBC1936 participants at age 76 (Table 1 and
Supplementary Tables 1 and 2). This remains the case
when we consider LBC1921 participants who dropped out
after the first wave of data collection. Possible explan-
ations for this include cohort effects, whereby those re-
cruited at age 79 are healthier (have longer telomeres, in
this instance) than those recruited at age 70 and who sur-
vive to age 76. Another explanation could be batch effects
of the assay. However, all samples were processed identi-
cally and at the same time. A recent study of telomere
length and age in over 100 000 individuals suggests that
telomere length declines over mid life but remains stable /
subtly increases in later life.32 Nonetheless, measurement
error and subtle batch effects in the telomere measures
Table 3. Mortality survival model output for Hannum methy-
lation age and telomere length
Covariate Hazard ratio 95% CI P-value
LBC1936 (n ¼ 920, nevents ¼ 135)
Age (years) 1.04 [0.84, 1.29] 0.69
Sex (female) 0.64 [0.45, 0.92] 0.016
Telomere length 0.96 [0.81, 1.14] 0.64
Hannum age 1.18 [1.01, 1.39] 0.036
LBC1921 (n ¼ 414, nevents ¼ 280)
Age (years) 0.97 [0.78, 1.20] 0.75
Sex (female) 0.86 [0.67, 1.10] 0.22
Telomere length 0.87 [0.76, 0.97] 0.013
Hannum age 1.22 [1.08, 1.38] 0.001
LBC1921 þ LBC1936 (n ¼ 1344, nevents ¼ 415)
Age (years) 1.12 [1.09, 1.15] < 2  1016
Sex (female) 0.79 [0.64, 0.97] 0.02
Telomere length 0.89 [0.80, 1.01] 0.06
Hannum age 1.22 [1.10, 1.37] 2.610-4
Effect sizes for telomere length and Hannum age are per standard
deviation.
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may have undermined the associations between it and
methylation age. We also observe a sizeable mean differ-
ence between the Hannum epigenetic age and chronolo-
gical age although, as previously reported,15 this intercept
effect is not overly concerning given the birth cohort data
that we are investigating. Moreover, the longitudinal
changes in the epigenetic clock estimates occur at the same
rate as chronological ageing in LBC1936, which gives us
confidence that they are tracking the process well. The
main limitation of the study is the relatively small sample
size, particularly for LBC1921 due to dropout for death,
and sub-group methylation typing at waves 2 and 3 in
LBC1936. However, very few datasets exist with both lon-
gitudinal (three-wave) telomere length and DNA methyla-
tion, particularly in this age range. A more complete
summary of the change in telomere length over time in
both LBC studies (including LBC1921 data at wave 5, age
92) is currently in preparation, along with concurrent
changes in physical and cognitive fitness.
The integration of the joint telomere-epigenetic clock
findings with the current literature is difficult as, to our
knowledge, this is the first time that such results have been
reported. The mortality results for the epigenetic clock
have been previously reported in both LBC1921 and
LBC1936 and are consistent with those found in two other
independent cohorts.15 The first telomere-mortality find-
ings described a near 2-fold increased risk for those with
short compared with long telomeres, along with increased
risks for some cause-specific mortality outcomes.33 When
considered as a continuous variable, telomere length re-
mained linked to an excess all-cause mortality risk.33 A
much larger study (n ¼ 64 637, n deaths ¼ 7607) confirms
these findings, reporting an increased all-cause mortality
risk of 40% for those in the decile of longest compared
with shortest telomeres.34
The cohorts’ narrow age range at each time point and
the follow-up period of 13 and 6 years, respectively,
means that our R2 estimates for predicting chronological
age are likely to be smaller than those obtained from co-
horts with a wider range of ages. This is particularly the
case for the epigenetic clock estimates, which typically
yield correlations of above 0.8 or 0.9 in samples with age
heterogeneity.2–4,15 Indeed, we observed an increased R2
for the epigenetic clock estimates when we combined the
two LBC studies into a single cohort. This pooled analysis
suggested that methylation age is a much better predictor
of chronological age (in old age) than telomere length.
Whether both the independence and the magnitudes of
the biological ageing estimates to predict chronological
age remain consistent in younger populations, where telo-
mere length is likely to be more effective in predicting
age,32 is unknown but of great interest. Another point
that needs to be considered in future studies is tissue spe-
cificity. Here, we measured telomere length and DNA
methylation in blood. Whether similar findings are seen
in other tissues is not known.
This study shows, for the first time, the relationship be-
tween two biological markers of ageing: telomere length
and the DNA methylation-based epigenetic clock. In our
data, both associate independently with chronological age.
The measures do not correlate with each other nor do dif-
ferences in baseline epigenetic clock measures predict
change in telomere length. Further research is warranted,
using datasets with more events/deaths, to robustly assess
the joint relationship between the two biological markers
of ageing and mortality. In summary, telomere length and
DNA methylation-based epigenetic clock estimates appear
to be tagging two different aspects of the ageing process.
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